Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

189

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
R03AL02	DUOLIN RESPULES	G	Salbutamol (sulfate) - 2.5mg/2.5ml, Ipratropium bromide (monohydrate) - 500mcg/2.5ml		Inhaltion solution with nebuliser	417,935 L.L
R03AL02	IPRASAL VEM	G	Salbutamol (sulfate) - 2.5mg/2.5ml, Ipratropium bromide (monohydrate) - 0.5mg/2.5ml		Inhaltion solution with nebuliser	417,935 L.L
R03AC02	ASTHALIN	G	Salbutamol (sulfate) - 2.5mg/2.5ml	2.5mg/2.5ml	Inhalation solution	325,210 L.L
R03AC02	RONKOTOL	G	Salbutamol (sulfate) - 2.5mg/2.5ml	2.5mg/2.5ml	Inhalation solution	470,345 L.L
R03AK13	BUTOSOL	G	Salbutamol (sulfate) - 100mcg/dose, Beclometasone dipropionate - 50mcg/dose		Metered dose inhaler	548,288 L.L
R03AC02	VENTOLIN EVOHALER	B	Salbutamol (sulfate) - 100mcg/dose	100mcg/dose	Inhalation aerosol metered dose	260,705 L.L
R03AC02	BUTALIN	G	Salbutamol (sulfate) - 100mcg/dose	100mcg/dose	Inhalation aerosol metered dose	145,135 L.L
A07FA02	ULTRA LEVURE	B	Saccharomyces boulardii - 50mg	50mg	Capsule	381,651 L.L
A07FA02	ULTRA LEVURE	B	Saccharomyces boulardii - 200mg	200mg	Capsule	513,348 L.L
A07FA02	ULTRA LEVURE	B	Saccharomyces boulardii - 100mg	100mg	Powder for suspension	536,193 L.L
L01EJ01	JAKAVI	B	Ruxolitinib - 5mg	5mg	Tablet	172,845,338 L.L
L01EJ01	CELEZON	G	Ruxolitinib - 5mg	5mg	Tablet	95,532,998 L.L
L01EJ01	CELEZON	G	Ruxolitinib - 5mg	5mg	Tablet	L.L
L01EJ01	JAKAVI	B	Ruxolitinib - 20mg	20mg	Tablet	341,075,567 L.L
L01EJ01	CELEZON	G	Ruxolitinib - 20mg	20mg	Tablet	188,515,591 L.L
L01EJ01	CELEZON	G	Ruxolitinib - 20mg	20mg	Tablet	L.L
L01EJ01	JAKAVI	B	Ruxolitinib - 15mg	15mg	Tablet	341,075,567 L.L
L01EJ01	CELEZON	G	Ruxolitinib - 15mg	15mg	Tablet	188,515,591 L.L
L01EJ01	CELEZON	G	Ruxolitinib - 15mg	15mg	Tablet	L.L
D11AH09	RUXOTOP	G	Ruxolitinib - 1.5%	1.5%	Cream	12,306,475 L.L
R06AX28	RUPATADINE BIOGARAN	G	Rupatadine - 10mg	10mg	Tablet	341,336 L.L
J07BD52	PRIORIX	B	Rubella virus live attenuated - ?10³ CCID50, Mumps virus live attenuated - ?103.7 CCID50, Measles virus live attenuated - ?10³ CCID50		Injectable lyophilised powder for solution+diluent	1,142,266 L.L
J07BD52	MEASLES, MUMPS AND RUBELLA VACCINE LIVE ATTENUATED (FREEZE-DRIED) MMR	G	Rubella virus live attenuated - ?1000CCID50 /0.5ml, Mumps virus live attenuated - ?5000CCID50 /0.5ml, Measles virus live attenuated - ?1000CCID50 /0.5ml		Injectable freeze dried powder + diluent	739,113 L.L
J07BD52	M-M-R II (MEASLES, MUMPS AND RUBELLA VIRUS VACCINE LIVE)	B	Rubella virus live attenuated - , Mumps virus live attenuated - , Measles virus live attenuated -		Injectable solution+diluent	12,924,401 L.L
J07BX05	ABRYSVO	B	RSV subgroup A stabilized perfusion F antigen 60mcg - 60mcg, RSV subgroup B stabilized perfusion F antigen 60mcg - 60mcg, Glycoprotein F stabilized in the perfusion conformation -		Injectable powder + solvent	22,650,721 L.L
N04BC09	NEUPRO	B	Rotigotine - 8mg/24h	8mg/24h	Patch	12,394,936 L.L
N04BC09	NEUPRO	B	Rotigotine - 6mg/24h	6mg/24h	Patch	9,427,593 L.L
N04BC09	NEUPRO	B	Rotigotine - 4mg/24h	4mg/24h	Patch	7,292,823 L.L
N04BC09	NEUPRO	B	Rotigotine - 2mg/24h	2mg/24h	Patch	4,427,961 L.L
J07BH01	ROTATEQ ROTAVIRUS VACCINE, LIVE, ORAL, PENTAVALENT	B	Rotavirus G1, live attenuated - ?2.2x106 IU, Rotavirus G2, live attenuated - ?2.8x106 IU, Rotavirus G3, live attenuated - ?2.2x106 IU, Rotavirus G4, live attenuated - ?2.0x106 IU, Rotavirus P1, live attenuated - ?2.3x106 IU		Suspension	4,508,592 L.L

...

189